CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 20 enrolled
Drug / intervention
Dakin's solution +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02203565
NCT02203565Phase 2Completed
CompareCT.gov

Pilot Study to Investigate the Impact of Hypochlorite in the Prevention of Radiation Dermatitis

Stanford University·interventional·Posted Jul 30, 2014·Updated Jul 26, 2017

In Brief

A Phase 2 clinical trial evaluating Dakin's solution, radiation therapy, and 2 other interventions for Breast Cancer and Skin Reactions Secondary to Radiation Therapy. Completed, enrolled 20 participants across 1 site.

Detailed Summary

This pilot clinical trial studies Dakin's solution in preventing radiation dermatitis in patients with breast cancer undergoing radiation therapy. Radiation dermatitis is a skin condition in which the affected skin becomes painful, red, itchy, and blistered. Dakin's solution may help reduce dermatitis caused by radiation therapy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer, Skin Reactions Secondary to Radiation Therapy
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
First PostedJul 30, 2014
Enrollment StartJul 1, 2014
Primary CompletionJul 7, 2016
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 11.9 years ago

Interventions

Dakin's solutiondrug

Applied topically

radiation therapyradiation

Undergo radiation therapy

questionnaire administrationother

Ancillary studies

laboratory biomarker analysisother

Optional correlative studies